168 related articles for article (PubMed ID: 33775851)
1. An extensive review to facilitate understanding of CRISPR technology as a gene editing possibility for enhanced therapeutic applications.
Rautela I; Uniyal P; Thapliyal P; Chauhan N; Bhushan Sinha V; Dev Sharma M
Gene; 2021 Jun; 785():145615. PubMed ID: 33775851
[TBL] [Abstract][Full Text] [Related]
2. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
3. Transforming plant biology and breeding with CRISPR/Cas9, Cas12 and Cas13.
Schindele P; Wolter F; Puchta H
FEBS Lett; 2018 Jun; 592(12):1954-1967. PubMed ID: 29710373
[TBL] [Abstract][Full Text] [Related]
4. The CRISPR/Cas revolution reaches the RNA world: Cas13, a new Swiss Army knife for plant biologists.
Wolter F; Puchta H
Plant J; 2018 Jun; 94(5):767-775. PubMed ID: 29575326
[TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas Systems towards Next-Generation Biosensing.
Li Y; Li S; Wang J; Liu G
Trends Biotechnol; 2019 Jul; 37(7):730-743. PubMed ID: 30654914
[TBL] [Abstract][Full Text] [Related]
6. Endogenous CRISPR-Cas System-Based Genome Editing and Antimicrobials: Review and Prospects.
Li Y; Peng N
Front Microbiol; 2019; 10():2471. PubMed ID: 31708910
[TBL] [Abstract][Full Text] [Related]
7. [The CRISPR-Cas system: beyond genome editing].
Croteau FR; Rousseau GM; Moineau S
Med Sci (Paris); 2018 Oct; 34(10):813-819. PubMed ID: 30451675
[TBL] [Abstract][Full Text] [Related]
8. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS
Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803
[TBL] [Abstract][Full Text] [Related]
9. Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins.
Lee J; Mir A; Edraki A; Garcia B; Amrani N; Lou HE; Gainetdinov I; Pawluk A; Ibraheim R; Gao XD; Liu P; Davidson AR; Maxwell KL; Sontheimer EJ
mBio; 2018 Dec; 9(6):. PubMed ID: 30514786
[TBL] [Abstract][Full Text] [Related]
10. Unleashing the potential of CRISPR multiplexing: Harnessing Cas12 and Cas13 for precise gene modulation in eye diseases.
Bigini F; Lee SH; Sun YJ; Sun Y; Mahajan VB
Vision Res; 2023 Dec; 213():108317. PubMed ID: 37722240
[TBL] [Abstract][Full Text] [Related]
11. Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications.
Liu C; Zhang L; Liu H; Cheng K
J Control Release; 2017 Nov; 266():17-26. PubMed ID: 28911805
[TBL] [Abstract][Full Text] [Related]
12. CRISPR: From Prokaryotic Immune Systems to Plant Genome Editing Tools.
Bandyopadhyay A; Mazumdar S; Yin X; Quick WP
Adv Exp Med Biol; 2017; 1016():101-120. PubMed ID: 29130156
[TBL] [Abstract][Full Text] [Related]
13. [The new generation tool for CRISPR genome editing: CRISPR/Cpf1].
Yang F; Li Y
Sheng Wu Gong Cheng Xue Bao; 2017 Mar; 33(3):361-371. PubMed ID: 28941336
[TBL] [Abstract][Full Text] [Related]
14. Creating cell and animal models of human disease by genome editing using CRISPR/Cas9.
Zarei A; Razban V; Hosseini SE; Tabei SMB
J Gene Med; 2019 Apr; 21(4):e3082. PubMed ID: 30786106
[TBL] [Abstract][Full Text] [Related]
15. CRISPR-Cas9 system: A new-fangled dawn in gene editing.
Gupta D; Bhattacharjee O; Mandal D; Sen MK; Dey D; Dasgupta A; Kazi TA; Gupta R; Sinharoy S; Acharya K; Chattopadhyay D; Ravichandiran V; Roy S; Ghosh D
Life Sci; 2019 Sep; 232():116636. PubMed ID: 31295471
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas9: Nature's gift to prokaryotes and an auspicious tool in genome editing.
Khanzadi MN; Khan AA
J Basic Microbiol; 2020 Feb; 60(2):91-102. PubMed ID: 31693214
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic applications of CRISPR/Cas9 system in gene therapy.
Mollanoori H; Teimourian S
Biotechnol Lett; 2018 Jun; 40(6):907-914. PubMed ID: 29704220
[TBL] [Abstract][Full Text] [Related]
18. Application of CRISPR/Cas9 gene editing technique in the study of cancer treatment.
Jiang C; Meng L; Yang B; Luo X
Clin Genet; 2020 Jan; 97(1):73-88. PubMed ID: 31231788
[TBL] [Abstract][Full Text] [Related]
19. [Application and optimization of CRISPR/Cas system in bacteria].
Fu J; Yang F; Xie H; Gu F
Sheng Wu Gong Cheng Xue Bao; 2019 Mar; 35(3):341-350. PubMed ID: 30912343
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9-mediated genome editing: From basic research to translational medicine.
Jacinto FV; Link W; Ferreira BI
J Cell Mol Med; 2020 Apr; 24(7):3766-3778. PubMed ID: 32096600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]